Impact of pancreatic enzyme replacement therapy (PERT) on survival in patients affected by advanced pancreatic ductal adenocarcinoma (PDAC) undergoing first-line chemotherapy
References (0)
Cited by (0)
Copyright © 2020 Published by Elsevier, a division of RELX India, Pvt. Ltd.